Mechanisms of Hormonal Regulation of the Sodium Chloride Cotransporter
氯化钠协同转运蛋白的激素调节机制
基本信息
- 批准号:8323954
- 负责人:
- 金额:$ 29.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-25 至 2015-08-31
- 项目状态:已结题
- 来源:
- 关键词:AlanineAldosteroneAngiotensin IIAnimal ExperimentationAntihypertensive AgentsBlood PressureCalcium-Sensing ReceptorsCell Culture TechniquesCell modelCellsChloride IonChloridesDataDevelopmentEndocytosisEpidermal Growth FactorEpidermal Growth Factor ReceptorGenerationsGlucocorticoidsHereditary DiseaseHormonalHormonesHypertensionImmunoblottingImmunohistochemistryInvestigationKidneyKnockout MiceKnowledgeLeadLeucine ZippersLinkLysineMAP Kinase GeneMAPK3 geneMammalian CellMediatingMediator of activation proteinMitogen Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3MolecularOxidative StressPathogenesisPathway interactionsPharmaceutical PreparationsPhosphorylationPhosphotransferasesPhysiologicalPlayProcessProlineProteinsPublishingRegulationRisk FactorsRoleSignal TransductionSiteSodiumSodium ChlorideStimulusSurfaceTransactivationTransgenic MiceTransgenic OrganismsTubular formationUbiquitinationWild Type Mouseabsorptionbasebiological adaptation to stressblood pressure regulationdefined contributionhormone regulationhuman diseasein vivoinsightmortalitypublic health relevancesalt balancesodium-chloride cotransporterthiazide
项目摘要
DESCRIPTION (provided by applicant): The thiazide-sensitive sodium chloride cotransporter (NCC) is one of the key determinants of salt balance and thus systemic blood pressure. However, in contrast to other important effectors of salt balance we know little about how hormonal and physiological signals alter activity of this cotransporter. Preliminary data demonstrates the role of the ERK1/2 MAPK (Extra-cellular signal-Regulated Kinases 1 and 2 Mitogen-Activated Protein Kinases) pathway in the ubiquitination and endocytosis of NCC. With-No-Lysine Kinase 1 and 4 (WNK1 and WNK4), Ste20-related proline alanine-rich kinase (SPAK) and Oxidative Stress Response-1 (OSR1) are also important regulators of NCC, and there is data that some hormones regulate NCC. However, a link between hormones and the intracellular pathways that mediate the effects of hormones on NCC has not been established. The broad hypothesis of the proposed investigation is that NCC is subject to hormonal regulation that proceeds through modulation of the kinases ERK1/2, SPAK/OSR and WNKs. Aim 1 will define the hormonal regulation of NCC through activation of ERK1/2 MAPK. ERK1/2 MAPK will be examined as a central mediator of the hormonal/physiological effects of Epidermal Growth Factor (EGF) and the Calcium-sensing Receptor (CaSR) on NCC. The mechanism of ERK1/2 activation and the roles of ubiquitination and endocytosis in this process will be thoroughly examined for each hormone, tracing a pathway from hormonal stimulus to functional effect. Aim 2 will determine the hormonal regulation of NCC by Aldosterone through ERK1/2 MAPK and SPAK/OSR and the mechanisms underlying these effects. ERK1/2 inhibition and SPAK/OSR activation by Aldosterone may lead to increased NCC activity. The role of WNKs in these pathways will be thoroughly examined. Aim 3 will determine the underlying molecular mechanisms mediating hormonal regulation of NCC by Angiotensin II. The roles of each of these kinase pathways will be examined with a particular emphasis on WNKs. Mammalian cell culture, isolated tubule microperfusion and whole animal experimentation will be utilized to examine effects at the cellular/molecular, tubular and organismal level. Knowledge of hormonal regulation of blood pressure has played a critical role in the development of new therapies to treat hypertension, the single risk factor that contributes the most to worldwide mortality. These studies will provide vital information on the regulation of this important effector of blood pressure homeostasis.
PUBLIC HEALTH RELEVANCE: The sodium chloride cotransporter (NCC) is an important salt absorptive pathway in the mammalian kidney that is the site of action of one of the most effective classes of anti- hypertensive medications and plays a key role in genetic disorders of hypertension. Despite the importance of this cotransporter in human disease, we know little about its hormonal regulation. This investigation of the hormonal regulation of this key effector of blood pressure will provide invaluable insight into the pathogenesis of Hypertension.
描述(由申请人提供):噻嗪敏感性氯化钠协同转运蛋白(NCC)是盐平衡的关键决定因素之一,因此也是全身血压的关键决定因素。然而,与盐平衡的其他重要效应物相比,我们对激素和生理信号如何改变这种协同转运蛋白的活性知之甚少。初步数据表明ERK 1/2 MAPK(细胞外信号调节激酶1和2丝裂原活化蛋白激酶)途径在NCC的泛素化和内吞作用中的作用。无赖氨酸激酶1和4(WNK 1和WNK 4)、与Ste 20相关的富含脯氨酸丙氨酸的激酶(SPAK)和氧化应激反应-1(OSR 1)也是NCC的重要调节因子,并且有数据表明一些激素调节NCC。然而,激素和介导激素对NCC作用的细胞内途径之间的联系尚未建立。所提出的研究的广泛假设是NCC受到激素调节,其通过激酶ERK 1/2、SPAK/OSR和WNK的调节进行。目的1阐明ERK 1/2 MAPK对NCC的激素调节作用。ERK 1/2 MAPK将作为表皮生长因子(EGF)和钙敏感受体(CaSR)对NCC的激素/生理作用的中心介质进行检查。ERK 1/2激活的机制和泛素化和内吞作用在这个过程中的作用将被彻底检查每种激素,跟踪从激素刺激到功能效应的途径。目的2探讨醛固酮通过ERK 1/2 MAPK和SPAK/OSR对NCC的激素调节作用及其机制。ERK 1/2抑制和SPAK/OSR激活醛固酮可能导致NCC活性增加。WNK在这些途径中的作用将被彻底研究。目的3将确定潜在的分子机制介导的激素调节NCC的血管紧张素II。这些激酶途径中的每一个的作用将被检查,特别强调WNK。将利用哺乳动物细胞培养、分离的小管微灌注和整体动物实验来检查细胞/分子、小管和生物体水平的效应。激素调节血压的知识在开发治疗高血压的新疗法中发挥了关键作用,高血压是导致全球死亡率最高的单一风险因素。这些研究将提供重要的信息调节血压稳态的这一重要效应。
公共卫生相关性:氯化钠协同转运蛋白(NCC)是哺乳动物肾脏中重要的盐吸收途径,是最有效的一类抗高血压药物的作用部位,并且在高血压遗传性疾病中起关键作用。尽管这种协同转运蛋白在人类疾病中很重要,但我们对其激素调节知之甚少。对这种血压关键效应物的激素调节的研究将为高血压的发病机制提供宝贵的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert S Hoover其他文献
Robert S Hoover的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert S Hoover', 18)}}的其他基金
NCC and ENaC form a Sodium Transporting Complex
NCC 和 ENaC 形成钠转运复合物
- 批准号:
9281535 - 财政年份:2015
- 资助金额:
$ 29.16万 - 项目类别:
NCC and ENaC form a Sodium Transporting Complex
NCC 和 ENaC 形成钠转运复合物
- 批准号:
8920893 - 财政年份:2015
- 资助金额:
$ 29.16万 - 项目类别:
Mechanisms of Hormonal Regulation of the Sodium Chloride Cotransporter
氯化钠协同转运蛋白的激素调节机制
- 批准号:
8721939 - 财政年份:2010
- 资助金额:
$ 29.16万 - 项目类别:
Mechanisms of Hormonal Regulation of the Sodium Chloride Cotransporter
氯化钠协同转运蛋白的激素调节机制
- 批准号:
7988140 - 财政年份:2010
- 资助金额:
$ 29.16万 - 项目类别:
Mechanisms of Hormonal Regulation of the Sodium Chloride Cotransporter
氯化钠协同转运蛋白的激素调节机制
- 批准号:
8532883 - 财政年份:2010
- 资助金额:
$ 29.16万 - 项目类别:
Mechanisms of Hormonal Regulation of the Sodium Chloride Cotransporter
氯化钠协同转运蛋白的激素调节机制
- 批准号:
8146163 - 财政年份:2010
- 资助金额:
$ 29.16万 - 项目类别:
相似海外基金
The study of aldosterone production machinery by angiotensin II metabolite
血管紧张素II代谢物产生醛固酮机制的研究
- 批准号:
24890308 - 财政年份:2012
- 资助金额:
$ 29.16万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Aldosterone breakthrough caused by chronic blockage of angiotensin II type-1 receptors in human adrenocortical cells : Involvement of bone morphogenetic protein-6 actions
人肾上腺皮质细胞中血管紧张素 II 1 型受体慢性阻断引起的醛固酮突破:骨形态发生蛋白 6 作用的参与
- 批准号:
21790894 - 财政年份:2009
- 资助金额:
$ 29.16万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
ALDOSTERONE, ANGIOTENSIN II AND SYMPATHETIC ACTIVATION IN HYPERTENSIVES
醛固酮、血管紧张素 II 和高血压患者的交感神经激活
- 批准号:
7604843 - 财政年份:2007
- 资助金额:
$ 29.16万 - 项目类别:
Angiotensin II, Aldosterone, Oxidation, and CaMKII in Hypertrophy and Arrhythmias
血管紧张素 II、醛固酮、氧化和 CaMKII 在肥厚和心律失常中的作用
- 批准号:
7665416 - 财政年份:2006
- 资助金额:
$ 29.16万 - 项目类别:
Mechanism of aldosterone-induced vascular injury: role of angiotensin II and other factors
醛固酮引起血管损伤的机制:血管紧张素II等因素的作用
- 批准号:
18590804 - 财政年份:2006
- 资助金额:
$ 29.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ALDOSTERONE, ANGIOTENSIN II AND SYMPATHETIC ACTIVATION IN HYPERTENSIVES
醛固酮、血管紧张素 II 和高血压患者的交感神经激活
- 批准号:
7377054 - 财政年份:2006
- 资助金额:
$ 29.16万 - 项目类别:
Angiotensin II, Aldosterone, Oxidation, and CaMKII in Hypertrophy and Arrhythmias
血管紧张素 II、醛固酮、氧化和 CaMKII 在肥厚和心律失常中的作用
- 批准号:
7146836 - 财政年份:2006
- 资助金额:
$ 29.16万 - 项目类别:
Angiotensin II, Aldosterone, Oxidation, and CaMKII in Hypertrophy and Arrhythmias
血管紧张素 II、醛固酮、氧化和 CaMKII 在肥厚和心律失常中的作用
- 批准号:
7496062 - 财政年份:2006
- 资助金额:
$ 29.16万 - 项目类别:
Angiotensin II, Aldosterone, Oxidation, and CaMKII in Hypertrophy and Arrhythmias
血管紧张素 II、醛固酮、氧化和 CaMKII 在肥厚和心律失常中的作用
- 批准号:
7279137 - 财政年份:2006
- 资助金额:
$ 29.16万 - 项目类别:
ALDOSTERONE, ANGIOTENSIN II AND SYMPATHETIC ACTIVATION IN HYPERTENSIVES
醛固酮、血管紧张素 II 和高血压患者的交感神经激活
- 批准号:
7201385 - 财政年份:2005
- 资助金额:
$ 29.16万 - 项目类别: